Fludarabine monophosphate in the treatment of patients with an advanced grade of B-chronic lymphatic leukaemia resistant to conventional chemotherapy;FLUDARABIN MONOFOSFAT V LECBE NEMOCNYCH S POKROCILYM STUPNEM B-CHRONICKE LYMFATICKE LEUKEMIE REZISTENTNI KE KONVENCNI CHEMOTERAPII

Vnitrni Lekarstvi

Volumn 43, Issue 1, 1997, Pages 25-28

  Papajik, T ^a   Faber, E ^a   Hubacek, J ^a   Slezak, P ^a   Raida, L ^a   Heczko, M ^a   Sulovska, I ^a   Jarosova, M ^a   Pikalova, Z ^a   Indrak, K ^a  

^a UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

Author keywords

Chronic lymphatic leukaemia; Fludarabine; Infectious complications

Indexed keywords

ANTINEOPLASTIC AGENT; FLUDARABINE; ANTINEOPLASTIC ANTIMETABOLITE; DRUG DERIVATIVE; FLUDARABINE PHOSPHATE; VIDARABINE PHOSPHATE;

ADULT; AGED; ARTICLE; ASPERGILLOSIS; CANCER CHEMOTHERAPY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; INFECTION; MALE; B CELL LEUKEMIA; MIDDLE AGED; RETROSPECTIVE STUDY;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; FEMALE; HUMANS; LEUKEMIA, B-CELL, CHRONIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; VIDARABINE PHOSPHATE;

EID: 0030626832     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)